REMPEVRY Trademark
REMPEVRY is a USPTO trademark filed by Pfizer Inc.. Status: Pending.
Prosecution Summary
**Trademark Summary** **REMPEVRY** is a standard character mark owned by **Pfizer Inc.**, a Delaware corporation based in New York, covering pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; anti-infectives, medicated dermatologicals and smoking cessation preparations; and vaccines for human use (class 005 primary), with additional domestic classes 006, 018, 044, 046, 051 and 052. The application is on an intent-to-use
Trademark Facts
| Mark | REMPEVRY |
|---|---|
| Serial Number | 99170033 |
| Status | Pending |
| Filing Date | 2025-05-05 |
| Mark Type | Word |
| Nice Classes | 005 (Pharmaceuticals) |
| Owner | Pfizer Inc. |
| Attorney of Record | Heather A. McDonald |
| Prosecution Events | 19 |
| Latest Event | EWAF on 2026-01-29 |
Goods & Services
Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human use.